Harbor Investment Advisory, LLC Agios Pharmaceuticals, Inc. Transaction History

Harbor Investment Advisory, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 14, 2023	BUY	$21.38 - $29.19 $4,639 - $6,334	217 Added 18.74%	1,375 $38,000
Q1 2022 Apr 20, 2022	BUY	$26.68 - $34.81 $6,243 - $8,145	234 Added 25.32%	1,158 $34,000
Q3 2021 Oct 12, 2021	SELL	$41.92 - $58.18 $193,125 - $268,035	-4,607 Reduced 83.29%	924 $43,000
Q1 2021 Apr 16, 2021	BUY	$44.23 - $57.5 $51,395 - $66,815	1,162 Added 26.6%	5,531 $286,000
Q4 2020 Feb 04, 2021	BUY	$33.21 - $46.54 $122,810 - $172,104	3,698 Added 551.12%	4,369 $189,000
Q3 2020 Oct 23, 2020	BUY	$33.87 - $55.93 $11,346 - $18,736	335 Added 99.7%	671 $23,000
Q1 2020 May 11, 2020	BUY	$31.52 - $53.81 $10,590 - $18,080	336 New	336 $12,000

232

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $3.05B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Harbor Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Harbor Investment Advisory, LLC with notifications on news.